Cargando…

Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique

Detalles Bibliográficos
Autores principales: Kromdijk, W., Sikma, M. A., van den Broek, M. P. H., Beijnen, J. H., Huitema, A. D. R., de Lange, D. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095329/
https://www.ncbi.nlm.nih.gov/pubmed/23443310
http://dx.doi.org/10.1007/s00134-013-2851-x
_version_ 1783510646755688448
author Kromdijk, W.
Sikma, M. A.
van den Broek, M. P. H.
Beijnen, J. H.
Huitema, A. D. R.
de Lange, D. W.
author_facet Kromdijk, W.
Sikma, M. A.
van den Broek, M. P. H.
Beijnen, J. H.
Huitema, A. D. R.
de Lange, D. W.
author_sort Kromdijk, W.
collection PubMed
description
format Online
Article
Text
id pubmed-7095329
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-70953292020-03-26 Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique Kromdijk, W. Sikma, M. A. van den Broek, M. P. H. Beijnen, J. H. Huitema, A. D. R. de Lange, D. W. Intensive Care Med Correspondence Springer-Verlag 2013-02-27 2013 /pmc/articles/PMC7095329/ /pubmed/23443310 http://dx.doi.org/10.1007/s00134-013-2851-x Text en © Springer-Verlag Berlin Heidelberg and ESICM 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Kromdijk, W.
Sikma, M. A.
van den Broek, M. P. H.
Beijnen, J. H.
Huitema, A. D. R.
de Lange, D. W.
Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
title Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
title_full Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
title_fullStr Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
title_full_unstemmed Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
title_short Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
title_sort pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095329/
https://www.ncbi.nlm.nih.gov/pubmed/23443310
http://dx.doi.org/10.1007/s00134-013-2851-x
work_keys_str_mv AT kromdijkw pharmacokineticsofoseltamivircarboxylateincriticallyillpatientseachpatientisunique
AT sikmama pharmacokineticsofoseltamivircarboxylateincriticallyillpatientseachpatientisunique
AT vandenbroekmph pharmacokineticsofoseltamivircarboxylateincriticallyillpatientseachpatientisunique
AT beijnenjh pharmacokineticsofoseltamivircarboxylateincriticallyillpatientseachpatientisunique
AT huitemaadr pharmacokineticsofoseltamivircarboxylateincriticallyillpatientseachpatientisunique
AT delangedw pharmacokineticsofoseltamivircarboxylateincriticallyillpatientseachpatientisunique